Sana Biotechnology EVP and President of R&D Resigns
Company Announcements

Sana Biotechnology EVP and President of R&D Resigns

Sana Biotechnology (SANA) just unveiled an announcement.

Douglas Williams, Ph.D., has voluntarily resigned from his roles as Executive Vice President and President of Research and Development at Sana Biotechnology, Inc., effective April 18, 2024. His departure is for personal reasons and does not stem from any disputes with the company.

See more insights into SANA stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlySana Biotechnology initiated with a Buy at Rodman & Renshaw
TheFlySana Biotechnology highlights publication in Nature Biotechnology
TheFlySana Biotechnology reports Q1 EPS (32c), consensus (32c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!